Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0865
+0.0014 (1.67%)
Aug 15, 2025, 3:53 PM EDT

PVCT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
365040452323
Upgrade
Market Cap Growth
-40.48%25.33%-11.35%96.93%-1.55%-5.21%
Upgrade
Enterprise Value
395343482346
Upgrade
Last Close Price
0.090.120.100.110.060.06
Upgrade
PS Ratio
79.0281.7972.2145.94--
Upgrade
PB Ratio
-6.19-8.46-5.30-7.29-5.51-0.78
Upgrade
EV/Sales Ratio
83.6786.0577.2548.64--
Upgrade
Debt / Equity Ratio
-0.43-0.53-0.40-0.35-0.42-0.79
Upgrade
Asset Turnover
0.580.500.320.36--
Upgrade
Quick Ratio
0.060.040.010.000.090.00
Upgrade
Current Ratio
0.090.140.150.230.450.01
Upgrade
Return on Assets (ROA)
-449.65%-200.92%-89.58%-64.62%-141.40%-298.62%
Upgrade
Earnings Yield
-17.51%-9.44%-7.70%-7.82%-24.01%-28.50%
Upgrade
FCF Yield
--6.51%-6.39%-6.69%-4.39%-17.44%
Upgrade
Buyback Yield / Dilution
-0.16%-0.07%-0.01%-2.76%-3.81%-1.72%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.